G40 serves as the primary category for epilepsy and recurrent epileptic seizures within the ICD-10-CM classification system. Epilepsy is a chronic neurological disorder characterized by an enduring predisposition to generate epileptic seizures and by the neurobiological, cognitive, psychological, and social consequences of this condition. A diagnosis generally requires at least two unprovoked seizures occurring more than 24 hours apart, or one unprovoked seizure and a probability of further seizures similar to the general recurrence risk after two unprovoked seizures. The abnormal electrical activity in the brain may be localized to a specific area (focal/partial) or involve both hemispheres (generalized). This category excludes isolated seizures, febrile seizures, and post-traumatic seizures unless the diagnostic criteria for epilepsy are met. Accurate classification within the G40 sub-codes depends on identifying the seizure onset, awareness during the event, and the presence of specific epileptic syndromes.
Distinguish between focal and generalized onset seizures to ensure precise ICD-10-CM sub-category selection.
Example: Patient with known localization-related epilepsy presents with focal seizures evolving to bilateral tonic-clonic activity. Documentation identifies the focal nature of the onset in the temporal lobe. Billing Focus: Identification of focal vs. generalized onset. Risk Adjustment: Specificity supports HCC 79 (Seizure Disorders and Convulsions).
Billing Focus: Seizure onset localization (focal, generalized, or unknown).
Explicitly document the presence or absence of intractability based on the failure of two or more appropriately chosen and tolerated antiepileptic drug regimens.
Example: Diagnosis: Localization-related (focal) symptomatic epilepsy with complex partial seizures, documented as intractable. Patient has failed trials of levetiracetam and lamotrigine at therapeutic doses. Billing Focus: Use of the term intractable or medically refractory. Risk Adjustment: Intractable epilepsy represents a higher severity level for risk adjustment models.
Billing Focus: Use of technical terms like intractable, pharmacoresistant, or treatment-resistant.
Document the occurrence of status epilepticus during the encounter or as the reason for admission.
Example: Patient admitted for generalized idiopathic epilepsy with status epilepticus. Prolonged seizure activity lasted 35 minutes despite benzodiazepine administration. Billing Focus: Inclusion of status epilepticus as a fifth or sixth character. Risk Adjustment: Status epilepticus significantly increases the risk profile and intensity of service.
Billing Focus: Duration of seizure activity meeting the criteria for status epilepticus.
Specify the nature of seizures such as absence, myoclonic, or tonic-clonic to align with specific G40 sub-codes.
Example: Childhood absence epilepsy, not intractable, without status epilepticus. History of frequent brief staring spells with 3Hz spike-and-wave on EEG. Billing Focus: Seizure morphology (absence vs. myoclonic). Risk Adjustment: Allows for precise mapping to pediatric epilepsy syndromes.
Billing Focus: Clinical seizure type (e.g., absence, tonic-clonic, myoclonic).
Identify the etiology of the epilepsy, such as post-traumatic, post-encephalitic, or genetic, when known.
Example: Post-traumatic epilepsy following a severe traumatic brain injury three years ago. Patient experiences focal impaired awareness seizures. Billing Focus: Linking the epilepsy to an underlying cause or history. Risk Adjustment: Demonstrates the sequelae of previous major medical events.
Billing Focus: Etiological factors and history of primary insult (e.g., trauma, stroke).
Typically used for patients with epilepsy experiencing breakthrough seizures or requiring medication adjustments.
Used for stable epilepsy patients on a maintenance medication regimen with no recent seizures.
Primary diagnostic tool for classifying seizure type and identifying epileptiform discharges.
Gold standard for evaluating patients for epilepsy surgery or confirming intractability.
Crucial for identifying structural lesions such as cortical dysplasia or hippocampal sclerosis.
Required for complex cases involving status epilepticus follow-up, multi-drug toxicity, or surgical planning.
Used for patients with Vagus Nerve Stimulators (VNS) for epilepsy control.
Standard for a new referral for seizure evaluation where the diagnosis of epilepsy is being established.
Initiation of multi-day monitoring for seizure quantification.
Required for patients with intractable epilepsy to assess cognitive side effects of medications or pre-surgical baseline.